Showing results (301-310 of 344) with videos related to
Sort By:
Pageof 35
Journal of Hepatology|November 9, 2010
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ programThierry Poynard, Mona Munteanu, Massimo Colombo, et al.The American Journal of Gastroenterology|September 1, 2021
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal AdherencePhilippe J Zamor, Ashley Brown, Douglas E Dylla, et al.Oncotarget|April 11, 2018
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinomaFarzaneh Moshiri, Alessandro Salvi, Laura Gramantieri, et al.Journal of Clinical Medicine|October 16, 2024
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-AdministrationValerio Rosato, Riccardo Nevola, Marcello Dallio, et al.JHEP Reports : Innovation in Hepatology|February 11, 2020
Liver fibrosis and CD206+ macrophage accumulation are suppressed by anti-GM-CSF therapyAlfonso Tan-Garcia, Fritz Lai, Joe Poh Sheng Yeong, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 28, 2017
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without CirrhosisTarik Asselah, Kris V Kowdley, Neddie Zadeikis, et al.Journal of Hepatology|December 19, 2015
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapyGeorge Papatheodoridis, George Dalekos, Vana Sypsa, et al.Journal of Hepatology|November 28, 2020
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Oveis Jamialahmadi, Serena Pelusi, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 12, 2023
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohortLoreta A Kondili, Maria Giovanna Quaranta, Luisa Cavalletto, et al.Hepatology International|April 13, 2020
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Monica Monti, et al.Pageof 35